Close Close

Life Health > Health Insurance

Insurers Praise Bushs Generic Drug Proposal

Your article was successfully shared with the contacts you provided.

Insurers Praise Bushs Generic Drug Proposal



Insurance companies are praising the Bush administrations proposed new rules aimed at increasing access to generic drugs, while consumer groups say the plan offers little relief to patients.

Donald A. Young, president of the Health Insurance Association of America, Washington, says the plan is an important step toward making health insurance more affordable.

“Over the last several years, prescription drug spending has grown more rapidly than other major categories of health care expenditures, helping to fuel the increase in health insurance premiums,” Young says.

The proposed rule, he says, should make lower cost generic medications more available.

Karen Ignagni, president of the American Association of Health Plans, Washington, adds that according to some estimates, the proposed rules could lead to significant consumer savings.

But Ron Pollack, executive director of Families USA, says that while the proposal is welcome, it is much weaker than legislation pending on Capitol Hill that makes it more difficult for brand name drug manufacturers to file frivolous new patents aimed at preventing generics from reaching the market.

Under the proposed rule, which the Bush administration says could save consumers $3 billion a year on prescription drug costs, the generic drug approval process would be accelerated.

Specifically, drug manufacturers would be allowed to file only one 30-month stay per generic drug application to resolve allegations that a generic drug maker is infringing on a patent.

The administration says 30 months is enough time to resolve cases of patent infringement. Multiple 30 month stays, which have led to delays in generic drug approval, would not be permitted.

In addition, the new proposal would make certain procedural changes in a Food and Drug Administration listing of drug patents aimed at reducing the opportunity to list inappropriate patents.

Reproduced from National Underwriter Life & Health/Financial Services Edition, October 28, 2002. Copyright 2002 by The National Underwriter Company in the serial publication. All rights reserved.Copyright in this article as an independent work may be held by the author.